Soho Biotech is a one-stop CDMO service supplier for the transformation of high-quality medical device scientific and technological achievements, providing a package of Marketing Authorization solutions such as research and development, product testing, animal testing, clinical trials, product registration to contract manufacturing, to accelerate the efficiency of commercialisation of medical achievements.

The Tissue Engineering and Regenerative Medicine Biomaterials Laboratory has achieved the transformation of scientific and technological achievements in "Engineering preparation technology and product development of low immunogenicity collagen and silk fibroin".The platform also reserves various research and development technologies of new generation mainstream medical materials such as hyaluronic acid, PLA, PLLA, pectin, PCL, peptides, polyethylene, PVA, polyurethane, polytetrafluoroethylene, microcrystalline calcium, chitosan, hydroxyapatite, humanized collagen, etc.

Silk Fibroin (SF) is a natural high polymer fibroin extracted from silk, the content of which is about 70% to 80% of the silk, containing 18 kinds of amino acids, with good mechanical properties and physicochemical properties, such as good flexibility and tensile strength, breathability and moisture permeability, and slow release.